Statement of Cash Flows	11 Months Ended
	Dec. 31, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (2,561,237)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by related party under promissory note	216
Change in fair value of derivative warrant liabilities	113,721
Gain from expiration of over-allotment option	(16,852)
Income from investments held in Trust Account	(14,984)
Offering costs associated with derivative warrant liabilities	240,974
Changes in operating assets and liabilities:
Prepaid expenses	(586,960)
Accrued expenses	6,000
Due to related party	5,380
Franchise tax payable	96,358
Accrued liabilities	1,793,478
Net cash used in operating activities	(923,906)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(168,515,980)
Net cash used in investing activities	(168,515,980)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from note payable to related party	100,139
Repayment of note payable to related party	(100,355)
Proceeds received from initial public offering, gross	168,515,980
Proceeds received from private placement	5,620,320
Offering costs paid	(3,998,565)
Net cash provided by financing activities	170,162,519
Net increase in cash	722,633
Cash - beginning of the period
Cash - end of the period	722,633
Supplemental disclosure of noncash activities:
Offering costs included in accrued expenses	70,000
Deferred underwriting commissions in connection with the initial public offering	$ 5,898,059